April 20-21, 2020

Paul Berg Hall, Li Ka Shing Center, Stanford

Advances in research and technology now afford us the unique opportunity to develop and test novel diagnostics and therapeutics. This conference takes advantage of the collective experience and expertise of our participants to cover a broad range of policy, research, and venture topics. This symposium provides an invaluable forum for interdisciplinary exchange at the forefront of drug research.
 

Lifetime Achievement Awardees

John Schiller, PhD

Deputy Chief, Laboratory of Cellular Oncology
National Cancer Institute

Douglas Lowy, MD

Director
National Cancer Institute

Participants

Hal Barron, MD

CSO and President
GlaxoSmithKline

Helen Blau, PhD

Donald E. and Delia B. Baxter Foundation Professor
Director
Baxter Laboratory for Stem Cell Biology

Anthony Fauci, MD

NIAID Director

Tom Hudson, MD

Chief Scientific Officer
AbbVie

Paula Kiberstis, PhD

Senior Editor
Science

Brian Kobilka, MD

Helen Irwin Fagan Chair in Cardiology, Stanford University
Nobel prize in 2012

Fady Malik, MD, PhD, FACC, FAHA

Executive Vice President, Research and Development, Cytokinetics

Ken Mills

President and CEO
REGENXBIO

Philip Pizzo, MD

David and Susan Heckerman Professor
Professor of Microbiology and Immunology
Emeritus Dean of Stanford School of Medicine

Lucy Shapiro, PhD

Director, Beckman Center for Molecular and Genetic Medicine
Stanford University School of Medicine

Roy Vagelos, MD

Retired Chairman and CEO, Merck
Chairman of the Board, Regeneron Pharmaceuticals

Michael Basson, PhD

Senior Editor
Nature Medicine

Robert Califf, MD

Head of Strategy and Policy
Verily Life Sciences and Google Health Divisions of Alphabet

Levi Garraway, MD, PhD

CMO
Genentech

Mir Imran

Chairman and CEO
Rani Therapeutics

Peter Kim, PhD

Virginia and D.K. Ludwig Professor of Biochemistry
Stanford University

Roger Kornberg, PhD

Mrs. George A. Winzer Professor in Medicine, Stanford University
Nobel prize winner, 2006

Mathai Mammen, MD, PhD

Global Head of Research and Development
Janssen

Lloyd Minor, MD

Carl and Elizabeth Naumann Professorship for the Dean, Stanford School of Medicine

William Rutter, PhD

Chairman and CEO
Synergenics

Mark Smith, MD, MBA

Founding President & CEO, California Healthcare Foundation

Janet Woodcock, MD

Director
Center for Drug Evaluation and Research
FDA

Elias Zerhouni, MD

Former President for Global R&D at Sanofi
Former Director of NIH
Former US Presidential Science Envoy

Howard Bauchner, MD

Editor in Chief
JAMA and the JAMA Network

Stanley Crooke, MD, PhD

Founder, Chairman, CEO
Ionis Pharmaceuticals

Christine Grady, RN, PhD

Chief of Bioethics
NIH

Cynthia Kenyon, PhD

Vice President of Aging Research
Calico

Stephen Knight, MD, MBA

President and Managing Partner
F-Prime Capital

Dean Li, MD, PhD

Senior Vice President, Discovery Sciences and Translational Medicine
Merck Research Laboratories

Joan Mannick, MD

Co-Founder and Chief Medical Officer
resTORbio

Michael Nedelman

Producer
CNN, Health & Medicine

Serge Saxonov

Co-Founder and CEO
10x Genomics

Eric Topol, MD

Executive Vice President, Scripps Research Institute; Director and Founder, Scripps Research Translational

Wendy Young, PhD

Senior Vice President, Small Molecule Drug Discovery
Genentech

Agenda

Organizers

Joseph C. Wu, MD, PhD

  • Director, Stanford CVI
  • Simon H. Stertzer, MD, Professor, Department of Medicine (Cardiology) and Radiology
    Stanford University School of Medicine

Amanda Chase, PhD

Grant Writer and Project Coordinator
Stanford Cardiovascular Institute

Sanjay Malhotra, PhD, FRSC

Associate Professor (Research) of Radiation Oncology (Radiation and Cancer Biology) and Radiology (MIPS)
Stanford University School of Medicine

Mark Mercola, PhD

Professor of Medicine (Cardiovascular)
Stanford University School of Medicine

Kuldev Singh, MD

Professor of Ophthalmology
Stanford University School of Medicine

Support by (alphabetical order)

Alexandria Real Estate

Cytokinetics